← All trials
NCT04581954
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 2, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Jul 31, 2021
- First posted
- Oct 9, 2020
- Last posted
- Nov 17, 2020
- Enrollment
- 456
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Imperial College LondonLead sponsor
- University of LondonCollaborator
- Imperial College LondonOverall official - principal investigator
- Rigel PharmaceuticalsCollaborator
- Imperial College LondonOfficial
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.